| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 619677 | Null | 0.00166561193816139 | 0.43420715 |
| NSC 631534 | Null | 0.00166561193816139 | 0.4459565 |
| NSC 635831 | Null | 0.00166561193816139 | 0.38689165 |
| NSC 643860 | Null | 0.00166561193816139 | 0.40123779 |
| NSC 644916 | ANTINEOPLASTIC-644916 | 0.00166561193816139 | 0.26446788 |
| NSC 673421 | Null | 0.00166561193816139 | 0.27590595 |
| NSC 705874 | Null | 0.00166561193816139 | 0.14197987 |
| NSC 718170 | Null | 0.00166561193816139 | 0.1504416 |
| NSC 744331 | (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd | 0.0016656119381614 | 0.27161586 |
| NSC 92504 | Null | 0.0016656119381614 | 0.34126623 |